TABLE 1.
Serum | Activity for VLP used to pretreat seraa
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
16wt | 16:BC | 16:DE | 16:EF | 16:FG | 16:HI | 16:FG/HI | 16:410 | 16:430 | 31wt | |
A | + | ND | + | + | + | + | + | + | + | + |
B | + | ND | + | + | ± | ± | − | + | + | − |
C | + | ND | − | + | − | − | ± | + | + | − |
D | + | ND | − | + | − | − | − | + | + | − |
E | + | ND | ± | − | ND | − | ± | + | + | − |
F | + | ND | − | + | ND | − | − | + | + | − |
G | + | ND | − | + | ND | − | ± | + | + | − |
H | + | ND | ± | ± | ND | − | ± | + | + | − |
ND, not done; +, high optical-density readings; −, low optical-density readings; ±, intermediate optical-density readings.